跳转至内容
Merck
CN

Z681822

CellCrown 插件

6 well plate inserts with 1.0 μm polycarbonate filter, sterile

别名:

3D, 3D 细胞培养

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NB.22
UNSPSC Code:
41122107
Material:
clear polycarbonate
Pore size:
1 μm
Sterility:
sterile
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


material

clear polycarbonate

sterility

sterile

feature

lid

packaging

pack of 3 ea

manufacturer/tradename

Scaffdex C10003F

size

6 wells

pore size

1 μm

General description

CellCrown 是一种一次性插件,可将样品固定在 6、12、24、48 和 96 孔板上。可以使用 CellCrown 将纤维、箔、膜、织物、组织和块状样品固定在孔中一个牢固的、可调节的位置。在更换培养基的过程中,可通过在孔壁和 CellCrown 插件之间进行移液,从而将样品留在孔中。使用 CellCrown 时,培养板的盖子是可以关闭的。该插件可以从孔板中取出,并在细胞培养后将其卸载,而不会损坏样品。CellCrown 由医用聚碳酸酯制成,产品线包括即用型无菌产品以及需要用户灭菌的非无菌产品。可以通过伽马射线或电子束辐射、高压灭菌、环氧乙烷气体和等离子灭菌进行灭菌。

灭菌条件:
温度....... 121°C/250°F
时间.................. 15 分钟
干燥时间......... 15 分钟
CellCrown 6 comes available as 5 models; non-sterile and sterile empty inserts and with preattached, white nylon membrane with pore size of 5 μm and with polycarbonate filter with pore size of 1 μm. Nylon filter is hydrophilic and binds proteins. Polycarbonate is the right material choice for the filter when cells and proteins are not wanted to attach on the filter.

Legal Information

CellCrown is a trademark of Scaffdex Oy


Still not finding the right product?

Explore all of our products under CellCrown 插件


法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容


Yangmei Zhang et al.
Artificial cells, nanomedicine, and biotechnology, 47(1), 3677-3686 (2019-12-17)
AMP-activated alpha 1 catalytic subunit (PRKAA1) is one of the subunits of the mammalian 5'-AMP-activated protein kinase (AMPK) playing an important role in maintaining intracellular energy metabolism and associating with the risk of gastric cancer (GC). This paper aims to
Elio Messi et al.
BMC cancer, 8, 30-30 (2008-01-31)
Neuroblastoma is a severe pediatric tumor, histologically characterised by a variety of cellular phenotypes. One of the pharmacological approaches to neuroblastoma is the treatment with retinoic acid. The mechanism of action of retinoic acid is still unclear, and the development
Patricia J Hunter et al.
Arthritis and rheumatism, 62(3), 896-907 (2010-02-04)
To identify biomarkers in the first synovial fluid (SF) aspirate obtained from children with oligoarticular juvenile idiopathic arthritis (JIA), which could be used to identify children whose disease is likely to extend to a more severe phenotype. Patients with recent-onset



全球贸易项目编号

货号GTIN
Z681822-3EA04061833571835